SCHEMBL379222

SCHEMBL379222

Clc1ccc(Nc2ccnc(Nc3ccc(Cl)cc3)n2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 4/20 0.69
NPC1 O15118 3/20 0.69
MAPT P10636 3/20 0.69
MAPK1 P28482 3/20 0.69
RAB9A P51151 3/20 0.69
MEN1 O00255 2/20 0.69
LMNA P02545 2/20 0.69
KMT2A Q03164 2/20 0.69
ALOX12 P18054 1/20 0.69
CDK2 P24941 2/20 0.68
CHEK1 O14757 1/20 0.68
IKBKB O14920 1/20 0.68
PDPK1 O15530 1/20 0.68
CHEK2 O96017 1/20 0.68
PRKCG P05129 1/20 0.68
CDK1 P06493 1/20 0.68
LYN P07948 1/20 0.68
KIT P10721 1/20 0.68
PIM1 P11309 1/20 0.68
FGFR1 P11362 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1183049 0.82 PLK1 (0.55) AURKANPC1MAPTMAPK1RAB9A
SCHEMBL1321961 0.81 AURKA (1.00) AURKANPC1MAPTMAPK1RAB9A
SCHEMBL4426737 0.81 AURKA (0.69) AURKANPC1MAPTMAPK1RAB9A
SCHEMBL29866211 0.81 AURKA (0.54) AURKANPC1MAPTMAPK1RAB9A
SCHEMBL28405713 0.81 AURKA (0.54) AURKANPC1MAPTMAPK1RAB9A
SCHEMBL440486 0.81 AURKA (1.00) AURKANPC1MAPTMAPK1RAB9A
SCHEMBL657412 0.80 MAPK1 (0.62) AURKANPC1MAPTMAPK1RAB9A
SCHEMBL14024356 0.80 KDR (0.66) AURKANPC1MAPTMAPK1RAB9A
SCHEMBL31337029 0.80 SCN9A (0.82) NPC1RAB9AKDRSCN9AKCNH2
SCHEMBL14380911 0.80 IGF1R (0.74) AURKANPC1MAPTMAPK1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2118279-B1 NOVEL COMPOSITION FOR TREATING METABOLIC SYNDROME IPINTL LLC (US) 2017-11-22 EP disclosed
EP-2702988-A2 Novel compositions and methods for treating hyperproliferative diseases Chen, Chien-Hung (US) 2014-03-05 EP disclosed
US-8486922-B2 Composition CHEN CHIEN-HUNG (TW) 2013-07-16 US disclosed
US-8431552-B2 first agent is an oxidative phosphorylation inhibitor (metformin) or an ionophore or an adenosine 5'-monophosphate-activated Protein kinase (AMPK) activator; second agent is antiinflammatory agent; and an third agent that possesses serotonin activity CHEN CHIEN-HUNG (US) 2013-04-30 US disclosed
US-8377947-B2 Treating alzheimer's disease and osteoporosis and reducing aging CHEN CHIEN-HUNG (US) 2013-02-19 US disclosed
US-8367645-B2 Compositions and methods for treating hyperproliferative diseases CHEN CHIEN-HUNG (US) 2013-02-05 US disclosed
EP-2494967-A1 Novel composition for treating metabolic syndrome IPINTL, LLC (US) 2012-09-05 EP disclosed
US-20120183600-A1 NOVEL COMPOSITION FOR TREATING METABOLIC SYNDROME AND OTHER CONDITIONS CHEN CHIEN-HUNG (US) 2012-07-19 US disclosed
EP-2408434-A1 TREATING ALZHEIMER'S DISEASE AND OSTEOPOROSIS AND REDUCING AGING IPINTL, LLC (US) 2012-01-25 EP disclosed
US-20110281829-A1 NOVEL COMPOSITION IPINTL, LLC (US) 2011-11-17 US disclosed
WO-2010107702-A1 TREATING ALZHEIMER'S DISEASE AND OSTEOPOROSIS AND REDUCING AGING IPINTL, LLC (US) 2010-09-23 WO disclosed
US-20100234295-A1 Treating Alzheimer's Disease And Osteoporosis And Reducing Aging CHEN CHIEN-HUNG 2010-09-16 US disclosed
EP-2123267-A1 Novel compositions and methods for treating hyperproliferative diseases Chen, Chien-Hung (US) 2009-11-25 EP disclosed
US-20090286760-A1 Novel Compositions and Methods for Treating Hyperproliferative Diseases CHEN CHIEN-HUNG 2009-11-19 US disclosed
WO-2009140680-A1 NOVEL COMPOSITIONS AND METHODS FOR TREATING HYPERPROLIFERATIVE DISEASES ALS MOUNTAIN LLC (US) 2009-11-19 WO disclosed
EP-2118279-A1 NOVEL COMPOSITION FOR TREATING METABOLIC SYNDROME IPINTL, LLC (US) 2009-11-18 EP disclosed
WO-2008089212-A1 NOVEL COMPOSITION FOR TREATING METABOLIC SYNDROME IPINTL, LLC (US) 2008-07-24 WO disclosed
US-20080176822-A1 NOVEL COMPOSITION FOR TREATING METABOLIC SYNDROME CHEN CHIEN-HUNG 2008-07-24 US disclosed